IT1294932B1 - Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie - Google Patents

Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie

Info

Publication number
IT1294932B1
IT1294932B1 IT97RM000569A ITRM970569A IT1294932B1 IT 1294932 B1 IT1294932 B1 IT 1294932B1 IT 97RM000569 A IT97RM000569 A IT 97RM000569A IT RM970569 A ITRM970569 A IT RM970569A IT 1294932 B1 IT1294932 B1 IT 1294932B1
Authority
IT
Italy
Prior art keywords
substituted
aminotethraline
pathologies
preparation
treatment
Prior art date
Application number
IT97RM000569A
Other languages
English (en)
Inventor
Piero Foresta
Vito Ruggiero
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT97RM000569A priority Critical patent/IT1294932B1/it
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to CN98810460A priority patent/CN1276721A/zh
Priority to KR1020007003076A priority patent/KR20010030670A/ko
Priority to NZ503391A priority patent/NZ503391A/en
Priority to PT98946704T priority patent/PT1017377E/pt
Priority to PCT/IT1998/000250 priority patent/WO1999015160A2/en
Priority to EP98946704A priority patent/EP1017377B1/en
Priority to MXPA00002774A priority patent/MXPA00002774A/es
Priority to SI9830040T priority patent/SI1017377T1/xx
Priority to AT98946704T priority patent/ATE209910T1/de
Priority to ES98946704T priority patent/ES2167942T3/es
Priority to BR9812489-7A priority patent/BR9812489A/pt
Priority to CA002303918A priority patent/CA2303918A1/en
Priority to JP2000512530A priority patent/JP2001517618A/ja
Priority to DK98946704T priority patent/DK1017377T3/da
Priority to AU93661/98A priority patent/AU735369B2/en
Priority to DE69802828T priority patent/DE69802828T2/de
Publication of ITRM970569A1 publication Critical patent/ITRM970569A1/it
Application granted granted Critical
Publication of IT1294932B1 publication Critical patent/IT1294932B1/it
Priority to US09/533,066 priority patent/US6242497B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT97RM000569A 1997-09-22 1997-09-22 Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie IT1294932B1 (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IT97RM000569A IT1294932B1 (it) 1997-09-22 1997-09-22 Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
ES98946704T ES2167942T3 (es) 1997-09-22 1998-09-18 Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes.
NZ503391A NZ503391A (en) 1997-09-22 1998-09-18 Use of 6,7-substituted 2-aminotetralines useful as for treating inflammatory and/or autoimmune disorders or diseases
PT98946704T PT1017377E (pt) 1997-09-22 1998-09-18 Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina
PCT/IT1998/000250 WO1999015160A2 (en) 1997-09-22 1998-09-18 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
EP98946704A EP1017377B1 (en) 1997-09-22 1998-09-18 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions
MXPA00002774A MXPA00002774A (es) 1997-09-22 1998-09-18 Uso de 2-aminotetralinas 6,7 substituidas adecuadas para preparar una composicion farmaceutica para el tratamiento de patologias inflamatorias y/o autoinmunitarias.
SI9830040T SI1017377T1 (en) 1997-09-22 1998-09-18 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions
CN98810460A CN1276721A (zh) 1997-09-22 1998-09-18 适于制备治疗炎症和/或自身免疫性疾病的药物组合物的6,7－取代的2－氨基－1,2,3,4－四氨化萘的用途
KR1020007003076A KR20010030670A (ko) 1997-09-22 1998-09-18 염증성 사이토카인에 의한 염증성 질환 및/또는 자가면역질환 치료를 위한 약제 조성물 제조에 유용한 6,7-치환2-아미노테트랄린의 용도
BR9812489-7A BR9812489A (pt) 1997-09-22 1998-09-18 Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes
CA002303918A CA2303918A1 (en) 1997-09-22 1998-09-18 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
JP2000512530A JP2001517618A (ja) 1997-09-22 1998-09-18 炎症性および／または自己免疫疾患の治療的処置のための医薬組成物を調製するのに適した６，７−置換２−アミノテトラリンの使用
DK98946704T DK1017377T3 (da) 1997-09-22 1998-09-18 Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande
AU93661/98A AU735369B2 (en) 1997-09-22 1998-09-18 Use of 6,7-substituted 2-aminotetralines suitable for preparing a pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
DE69802828T DE69802828T2 (de) 1997-09-22 1998-09-18 Verwendung von 6,7-substituierter 2-aminotetraline zur behandlung von zytokin-vermittleten entzündungszuständen
AT98946704T ATE209910T1 (de) 1997-09-22 1998-09-18 Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen
US09/533,066 US6242497B1 (en) 1997-09-22 2000-03-22 Use of 6,7-substituted 2-aminotetralines suitable for preparing a pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000569A IT1294932B1 (it) 1997-09-22 1997-09-22 Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie

Publications (2)

Publication Number Publication Date
ITRM970569A1 ITRM970569A1 (it) 1999-03-22
IT1294932B1 true IT1294932B1 (it) 1999-04-23

Family

ID=11405258

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000569A IT1294932B1 (it) 1997-09-22 1997-09-22 Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie

Country Status (17)

Country Link
US (1) US6242497B1 (it)
EP (1) EP1017377B1 (it)
JP (1) JP2001517618A (it)
KR (1) KR20010030670A (it)
CN (1) CN1276721A (it)
AT (1) ATE209910T1 (it)
AU (1) AU735369B2 (it)
BR (1) BR9812489A (it)
CA (1) CA2303918A1 (it)
DE (1) DE69802828T2 (it)
DK (1) DK1017377T3 (it)
ES (1) ES2167942T3 (it)
IT (1) IT1294932B1 (it)
MX (1) MXPA00002774A (it)
NZ (1) NZ503391A (it)
PT (1) PT1017377E (it)
WO (1) WO1999015160A2 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
JP5738875B2 (ja) * 2009-10-16 2015-06-24 エピオメド セラピューティクス， インク． 催吐治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Also Published As

Publication number Publication date
BR9812489A (pt) 2000-09-26
MXPA00002774A (es) 2002-10-31
AU9366198A (en) 1999-04-12
DE69802828T2 (de) 2002-07-18
DK1017377T3 (da) 2002-03-04
KR20010030670A (ko) 2001-04-16
ES2167942T3 (es) 2002-05-16
US6242497B1 (en) 2001-06-05
CA2303918A1 (en) 1999-04-01
ATE209910T1 (de) 2001-12-15
EP1017377A2 (en) 2000-07-12
CN1276721A (zh) 2000-12-13
JP2001517618A (ja) 2001-10-09
AU735369B2 (en) 2001-07-05
WO1999015160A2 (en) 1999-04-01
NZ503391A (en) 2001-06-29
ITRM970569A1 (it) 1999-03-22
EP1017377B1 (en) 2001-12-05
DE69802828D1 (de) 2002-01-17
PT1017377E (pt) 2002-04-29
WO1999015160A3 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
YU45293A (sh) Morfolin i tiomorfolin tahikinin antagonisti receptora
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
FI963070A0 (fi) Klooripyrimidiinivälituotteita
IT8721618A0 (it) Prodecimento per la depurazione bilogica di acque reflue.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ATE232396T1 (de) Oxydiertes thymosin beta 4
ATE231872T1 (de) Thiazolopyrimidinderivate
EA199901013A1 (ru) Гели пролонгированного действия
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
IT1285770B1 (it) Composti corticoidei
SE9801494D0 (sv) Novel use
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
PT1017667E (pt) 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
BG100248A (bg) Инхибитори на скваленсинтетаза
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
ATE305517T1 (de) Neurotrypsin
BR0011261B1 (pt) composiÇço oral compreendendo perlita, e, uso de perlita.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes
ATE57526T1 (de) P-acylaminobenzamide.
ITRM950143A0 (it) Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di composizioni farmaceutiche antipiretiche ed antinfiammatorie.

Legal Events

Date Code Title Description
0001 Granted